Company Filing History:
Years Active: 2005
Title: Gerarado A Zapata: Innovator in Antibody Fragment-Polymer Conjugates
Introduction
Gerarado A Zapata is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody fragment-polymer conjugates. His work focuses on innovative solutions for diagnostic applications and the treatment of inflammatory disorders.
Latest Patents
Gerarado A Zapata holds 1 patent for his invention titled "Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies." This patent describes humanized anti-IL-8 monoclonal antibodies and their variants, which are designed for use in diagnostic applications and therapeutic interventions. The invention also details a conjugate formed by an antibody fragment covalently attached to a non-proteinaceous polymer, achieving an apparent size of at least about 500 kD. This conjugate demonstrates substantially improved half-life, mean residence time, and clearance rate in circulation compared to the underivatized parental antibody fragment.
Career Highlights
Gerarado A Zapata is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to further explore and refine his inventions in the field of monoclonal antibodies.
Collaborations
Throughout his career, Gerarado has collaborated with talented individuals such as Vanessa Hsei and Iphigenia Koumenis. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Gerarado A Zapata is a distinguished inventor whose work in antibody fragment-polymer conjugates has the potential to revolutionize treatments for inflammatory disorders. His contributions to biotechnology continue to pave the way for innovative solutions in the medical field.